XenoPort, Inc. Presents New Analyses Of Data For Gabapentin Enacarbil At The 33rd Annual Scientific Meeting Of The American Pain Society
Published: Apr 30, 2014
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will present new analyses of data for gabapentin enacarbil (GEn), the active ingredient in HORIZANT® (gabapentin enacarbil) Extended-Release Tablets, at the 33rd Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.
Help employers find you! Check out all the jobs and post your resume.